NIH Requests Comments on Proposal to Amend Guidelines on Genetic Research

The National Institutes of Health (NIH) is seeking public comment on a proposal to amend the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. The proposal is intended to “streamline the oversight of human gene transfer clinical research protocols or gene therapy research and reduce duplicative reporting requirements already captured within the existing regulatory framework.” The agency proposes removing the NIH protocol submission, review, and reporting requirements under the current guidelines and modifying the responsibilities of the Recombinant DNA Advisory Committee (RAC). Comments on the proposal will be accepted until October 16, 2018. Comments may be submitted electronically here: https://osp.od.nih.gov/comment-form-nih-guidelines/ Questions about the proposal may be directed to the NIH Office of Science Policy at SciencePolicy@od.nih.gov. Click here for more information on the proposal: https://www.gpo.gov/fdsys/pkg/FR-2018-08-17/html/2018-17760.htm      
Source: Public Policy Reports - Category: Biology Authors: Source Type: news